Effect of dose of GnRH analog on ovulation in mares

E. L. Squires, D. M. Moran, M. E. Farlin, D. J. Jasko, T. J. Keefe, Stuart A Meyers, E. Figueiredo, P. M. McCue, W. Jochle

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Proper timing of insemination for optimal conception is accomplished by frequent palpations per rectum, by ultrasonography of the preovulatory follicle and/or by treatment with hCG or GnRH. Sustained release of GnRH from implants has been shown to hasten ovulation. Therefore, 2 studies were conducted to evaluate the efficacy of a GnRH analog, deslorelin, for hastening ovulation in nonlactating cyclic mares. The GnRH implant was 2.3 × 3.7 mm and released deslorelin for 2 to 3 days. In Experiment 1, 60 nonlactating, cycling mares were assigned to 1 of 5 doses: 0, 1.2, 1.7, 2.2 and 2.7 mg per implant. Mares were assigned sequentially on the first day of estrus (Day 1). Ovaries were examined per rectum and with ultrasonography every 12 h until ovulation. Once the mares obtained a follicle >30 mm, they were injected subcutaneously with a GnRH implant. The mares were inseminated every other day during estrus with semen from 1 of 3 stallions. Pregnancy was determined with ultrasonography. Experiment 2, 40 nonlactating, cyclic mares were assigned to 1 of 5 treatments (same treatments as in Experiment 1). Data were obtained on interval to ovulation, duration of estrus and pregnancy rates at 12, 18 and 35 d after ovulation. Time to ovulation was shorter (P<0.05) in GnRH-treated mares than in control mares in the Experiment 1. Mean time to ovulation was 68, 49, 48, 47, 44 h in Experiment 1, and 91, 66, 58, 46, 58 h in Experiment 2 for mares given 0, 1.2, 1.7, 2.2 and 2.7 mg/mare in the 2 trials. Averaged for both experiments, the proportion of mares ovulating within 48 h of treatment was 40, 75, 85, 90 and 90% for 0, 1.2, 1.7, 2.2 and 2.7 mg/mare. For both experiments, there was no effect of GnRH on pregnancy rate. In summary, a subcutaneous implant containing GnRH analog induced ovulation in most mares by 48 h of injection, and there was no advantage of doses higher than 2.2 mg/mare.

Original languageEnglish (US)
Pages (from-to)757-769
Number of pages13
JournalTheriogenology
Volume41
Issue number3
DOIs
StatePublished - Feb 2 1994

Fingerprint

Ovulation
Gonadotropin-Releasing Hormone
mares
ovulation
dosage
Estrus
Ultrasonography
Pregnancy Rate
Rectum
ultrasonography
estrus
rectum
Insemination
Palpation
pregnancy rate
Semen
Ovary
Therapeutics
Pregnancy
Injections

Keywords

  • GnRH analog
  • horses
  • ovulation

ASJC Scopus subject areas

  • Animal Science and Zoology
  • veterinary(all)

Cite this

Squires, E. L., Moran, D. M., Farlin, M. E., Jasko, D. J., Keefe, T. J., Meyers, S. A., ... Jochle, W. (1994). Effect of dose of GnRH analog on ovulation in mares. Theriogenology, 41(3), 757-769. https://doi.org/10.1016/0093-691X(94)90185-L

Effect of dose of GnRH analog on ovulation in mares. / Squires, E. L.; Moran, D. M.; Farlin, M. E.; Jasko, D. J.; Keefe, T. J.; Meyers, Stuart A; Figueiredo, E.; McCue, P. M.; Jochle, W.

In: Theriogenology, Vol. 41, No. 3, 02.02.1994, p. 757-769.

Research output: Contribution to journalArticle

Squires, EL, Moran, DM, Farlin, ME, Jasko, DJ, Keefe, TJ, Meyers, SA, Figueiredo, E, McCue, PM & Jochle, W 1994, 'Effect of dose of GnRH analog on ovulation in mares', Theriogenology, vol. 41, no. 3, pp. 757-769. https://doi.org/10.1016/0093-691X(94)90185-L
Squires EL, Moran DM, Farlin ME, Jasko DJ, Keefe TJ, Meyers SA et al. Effect of dose of GnRH analog on ovulation in mares. Theriogenology. 1994 Feb 2;41(3):757-769. https://doi.org/10.1016/0093-691X(94)90185-L
Squires, E. L. ; Moran, D. M. ; Farlin, M. E. ; Jasko, D. J. ; Keefe, T. J. ; Meyers, Stuart A ; Figueiredo, E. ; McCue, P. M. ; Jochle, W. / Effect of dose of GnRH analog on ovulation in mares. In: Theriogenology. 1994 ; Vol. 41, No. 3. pp. 757-769.
@article{bb0b66a0a566456b97829fea3c6b5b92,
title = "Effect of dose of GnRH analog on ovulation in mares",
abstract = "Proper timing of insemination for optimal conception is accomplished by frequent palpations per rectum, by ultrasonography of the preovulatory follicle and/or by treatment with hCG or GnRH. Sustained release of GnRH from implants has been shown to hasten ovulation. Therefore, 2 studies were conducted to evaluate the efficacy of a GnRH analog, deslorelin, for hastening ovulation in nonlactating cyclic mares. The GnRH implant was 2.3 × 3.7 mm and released deslorelin for 2 to 3 days. In Experiment 1, 60 nonlactating, cycling mares were assigned to 1 of 5 doses: 0, 1.2, 1.7, 2.2 and 2.7 mg per implant. Mares were assigned sequentially on the first day of estrus (Day 1). Ovaries were examined per rectum and with ultrasonography every 12 h until ovulation. Once the mares obtained a follicle >30 mm, they were injected subcutaneously with a GnRH implant. The mares were inseminated every other day during estrus with semen from 1 of 3 stallions. Pregnancy was determined with ultrasonography. Experiment 2, 40 nonlactating, cyclic mares were assigned to 1 of 5 treatments (same treatments as in Experiment 1). Data were obtained on interval to ovulation, duration of estrus and pregnancy rates at 12, 18 and 35 d after ovulation. Time to ovulation was shorter (P<0.05) in GnRH-treated mares than in control mares in the Experiment 1. Mean time to ovulation was 68, 49, 48, 47, 44 h in Experiment 1, and 91, 66, 58, 46, 58 h in Experiment 2 for mares given 0, 1.2, 1.7, 2.2 and 2.7 mg/mare in the 2 trials. Averaged for both experiments, the proportion of mares ovulating within 48 h of treatment was 40, 75, 85, 90 and 90{\%} for 0, 1.2, 1.7, 2.2 and 2.7 mg/mare. For both experiments, there was no effect of GnRH on pregnancy rate. In summary, a subcutaneous implant containing GnRH analog induced ovulation in most mares by 48 h of injection, and there was no advantage of doses higher than 2.2 mg/mare.",
keywords = "GnRH analog, horses, ovulation",
author = "Squires, {E. L.} and Moran, {D. M.} and Farlin, {M. E.} and Jasko, {D. J.} and Keefe, {T. J.} and Meyers, {Stuart A} and E. Figueiredo and McCue, {P. M.} and W. Jochle",
year = "1994",
month = "2",
day = "2",
doi = "10.1016/0093-691X(94)90185-L",
language = "English (US)",
volume = "41",
pages = "757--769",
journal = "Theriogenology",
issn = "0093-691X",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Effect of dose of GnRH analog on ovulation in mares

AU - Squires, E. L.

AU - Moran, D. M.

AU - Farlin, M. E.

AU - Jasko, D. J.

AU - Keefe, T. J.

AU - Meyers, Stuart A

AU - Figueiredo, E.

AU - McCue, P. M.

AU - Jochle, W.

PY - 1994/2/2

Y1 - 1994/2/2

N2 - Proper timing of insemination for optimal conception is accomplished by frequent palpations per rectum, by ultrasonography of the preovulatory follicle and/or by treatment with hCG or GnRH. Sustained release of GnRH from implants has been shown to hasten ovulation. Therefore, 2 studies were conducted to evaluate the efficacy of a GnRH analog, deslorelin, for hastening ovulation in nonlactating cyclic mares. The GnRH implant was 2.3 × 3.7 mm and released deslorelin for 2 to 3 days. In Experiment 1, 60 nonlactating, cycling mares were assigned to 1 of 5 doses: 0, 1.2, 1.7, 2.2 and 2.7 mg per implant. Mares were assigned sequentially on the first day of estrus (Day 1). Ovaries were examined per rectum and with ultrasonography every 12 h until ovulation. Once the mares obtained a follicle >30 mm, they were injected subcutaneously with a GnRH implant. The mares were inseminated every other day during estrus with semen from 1 of 3 stallions. Pregnancy was determined with ultrasonography. Experiment 2, 40 nonlactating, cyclic mares were assigned to 1 of 5 treatments (same treatments as in Experiment 1). Data were obtained on interval to ovulation, duration of estrus and pregnancy rates at 12, 18 and 35 d after ovulation. Time to ovulation was shorter (P<0.05) in GnRH-treated mares than in control mares in the Experiment 1. Mean time to ovulation was 68, 49, 48, 47, 44 h in Experiment 1, and 91, 66, 58, 46, 58 h in Experiment 2 for mares given 0, 1.2, 1.7, 2.2 and 2.7 mg/mare in the 2 trials. Averaged for both experiments, the proportion of mares ovulating within 48 h of treatment was 40, 75, 85, 90 and 90% for 0, 1.2, 1.7, 2.2 and 2.7 mg/mare. For both experiments, there was no effect of GnRH on pregnancy rate. In summary, a subcutaneous implant containing GnRH analog induced ovulation in most mares by 48 h of injection, and there was no advantage of doses higher than 2.2 mg/mare.

AB - Proper timing of insemination for optimal conception is accomplished by frequent palpations per rectum, by ultrasonography of the preovulatory follicle and/or by treatment with hCG or GnRH. Sustained release of GnRH from implants has been shown to hasten ovulation. Therefore, 2 studies were conducted to evaluate the efficacy of a GnRH analog, deslorelin, for hastening ovulation in nonlactating cyclic mares. The GnRH implant was 2.3 × 3.7 mm and released deslorelin for 2 to 3 days. In Experiment 1, 60 nonlactating, cycling mares were assigned to 1 of 5 doses: 0, 1.2, 1.7, 2.2 and 2.7 mg per implant. Mares were assigned sequentially on the first day of estrus (Day 1). Ovaries were examined per rectum and with ultrasonography every 12 h until ovulation. Once the mares obtained a follicle >30 mm, they were injected subcutaneously with a GnRH implant. The mares were inseminated every other day during estrus with semen from 1 of 3 stallions. Pregnancy was determined with ultrasonography. Experiment 2, 40 nonlactating, cyclic mares were assigned to 1 of 5 treatments (same treatments as in Experiment 1). Data were obtained on interval to ovulation, duration of estrus and pregnancy rates at 12, 18 and 35 d after ovulation. Time to ovulation was shorter (P<0.05) in GnRH-treated mares than in control mares in the Experiment 1. Mean time to ovulation was 68, 49, 48, 47, 44 h in Experiment 1, and 91, 66, 58, 46, 58 h in Experiment 2 for mares given 0, 1.2, 1.7, 2.2 and 2.7 mg/mare in the 2 trials. Averaged for both experiments, the proportion of mares ovulating within 48 h of treatment was 40, 75, 85, 90 and 90% for 0, 1.2, 1.7, 2.2 and 2.7 mg/mare. For both experiments, there was no effect of GnRH on pregnancy rate. In summary, a subcutaneous implant containing GnRH analog induced ovulation in most mares by 48 h of injection, and there was no advantage of doses higher than 2.2 mg/mare.

KW - GnRH analog

KW - horses

KW - ovulation

UR - http://www.scopus.com/inward/record.url?scp=0005552543&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0005552543&partnerID=8YFLogxK

U2 - 10.1016/0093-691X(94)90185-L

DO - 10.1016/0093-691X(94)90185-L

M3 - Article

C2 - 16727430

AN - SCOPUS:0005552543

VL - 41

SP - 757

EP - 769

JO - Theriogenology

JF - Theriogenology

SN - 0093-691X

IS - 3

ER -